Planet Flem/Digital Vision Vectors//Getty Images
For stories on the science of healthy living, subscribe to NPR's Health newsletter.
An experimental drug doctors hoped would be the next big advance in preventing heart attacks and strokes failed a crucial test, researchers reported Saturday.
The medicine, which reduces levels of a particle in the blood associated with heart attacks and strokes, didn't protect volunteers in a closely watched study.
"I was shocked. I had high hopes for success," says Steven Nissen , a cardiologist at the Cleveland Clinic who led the study. "Cardiovascular disease is still the leading cause of death in developed countries. And so we really were hoping to find additional therapies that would reduce risk."
The research aimed to help people who seem to do everything right. They keep their cholesterol and blood pressure low, eat well, maintain a healthy weight, and exercise regularly.…